Table 12 Selected studies for ALL therapy from 2020 ASH annual meeting
Abstract # | Authors (reference) | Study agents | Phase | NCT No |
|---|---|---|---|---|
465 | Short et al. [148] | Ponatinib Venetoclax dexamethasone | I/II | 03576547 |
3347 | Ghobadi et al. [151] | AlloHSCT versus chemotherapy | Multicenter Retrospective | |
1014 | Short et al. [155] | MiniHCVD Inotuzumab ozogamicin Blinatumomab | II | |
163 | Jain et al. [158] | UCART22 | I | 04150497 |
499 | Hu et al. [159] | CTA101 | I | 04154709 |